Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27151407)

Published in J Exp Clin Cancer Res on May 06, 2016

Authors

Piwen Wang1,2, Susanne M Henning3, Clara E Magyar4, Yahya Elshimali5, David Heber3, Jaydutt V Vadgama5,6

Author Affiliations

1: Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA, 90059, USA. piwenwang@cdrewu.edu.
2: Center for Human Nutrition, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. piwenwang@cdrewu.edu.
3: Center for Human Nutrition, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
4: Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
5: Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA, 90059, USA.
6: Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Articles cited by this

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med (2008) 5.74

The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer (2013) 4.20

Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev Cell (2002) 2.96

MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med (2014) 2.78

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol (2011) 2.74

Hepatotoxicity of chemotherapy. Oncologist (2001) 2.02

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene (2009) 1.61

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology (1999) 1.53

Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res (2003) 1.50

Roles for growth factors in cancer progression. Physiology (Bethesda) (2010) 1.48

Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate (2014) 1.47

Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem (2007) 1.41

Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. ChemMedChem (2007) 1.26

Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis. Proc Natl Acad Sci U S A (2012) 1.23

Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro. PLoS One (2013) 1.11

miRNA as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med (2013) 1.08

Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS One (2012) 1.08

Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res (2011) 1.06

Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience. Anticancer Drugs (1995) 1.06

microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells. Oncol Rep (2013) 1.03

Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J Nutr Biochem (2013) 1.02

Effect of quercetin on inflammatory gene expression in mice liver in vivo - role of redox factor 1, miRNA-122 and miRNA-125b. Pharmacol Res (2012) 1.01

Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther (2010) 1.00

Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer. Prostate (2012) 0.97

Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct (2012) 0.96

High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer. Anticancer Res (2004) 0.95

Cancer-linked targets modulated by curcumin. Int J Biochem Mol Biol (2012) 0.91

Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr Cancer (2012) 0.89

Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C. J Exp Clin Cancer Res (2015) 0.88

Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo. J Exp Clin Cancer Res (2015) 0.85

EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1). Arch Toxicol (2014) 0.83

Castration-resistant prostate cancer: new science and therapeutic prospects. Ther Adv Med Oncol (2010) 0.80

Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (review). Int J Oncol (2014) 0.80

Sensitization to docetaxel in prostate cancer cells by green tea and quercetin. J Nutr Biochem (2015) 0.79

MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma. J Exp Clin Cancer Res (2016) 0.78

Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Mol Nutr Food Res (2014) 0.77